Evergrande Health is now Evergrande Auto

An interesting name change in China. The Evergrande Health Industry Group Limited (Evergrande Health) becomes the China Evergrande New Energy Vehicle Group (Evergrande Auto). The company announced the renaming yesterday on the Hong Kong stock exchange where the shares are traded.

Evergrande Health becomes Evergrande Auto

The name change is more than just a change of name. Commentators indicate a rebalancing of the future business model. This makes it clear that the automotive industry is the most important business area of ​​the future for Evergrande.

Evergrande has big ambitions

Evergrande Auto is building several with investments worth billions Workswhich are expected to be completed by the end of the year. Yesterday, the company again emphasized its plan to become the world's largest supplier of vehicles with alternative drives in 3 to 5 years.

For Evergande, the Chinese market comes first, then export. Regardless of this, the future of Trollhättan is an exciting question from a European perspective. The complete takeover of NEVS and the former Saab plant should be completed in September at the latest. It is currently unclear what Evergrande Auto is planning with it. The plant is strategically located in the EU, so supplying all European countries is not a problem.

From Saab to Evergrande?

What is happening in Trollhättan? Will the NEVS lettering shine over the old Saab halls in the future? Or will it disappear and Evergrande Auto makes a statement in Sweden? Will NEVS go down in history as a footnote, or continue to exist alongside Hengchi as a sub-brand in the Evergrande Auto realm?

We will see.

One thought on "Evergrande Health is now Evergrande Auto"

  • blank

    It would be interesting to know what the realm of Evergrande Auto produces and when. A very interesting SZ article on the status of many e-car projects (https://www.sueddeutsche.de/auto/pleitewelle-bei-jungen-autofirmen-gute-zeiten-schlechte-zeiten-1.4961234) also mentions Evergrande and that one of the many development partners presented is said to have dropped out again.

    At the moment it is difficult to estimate which delay Corona is owed (everyone has the problem and it should be over at some point) and which delay may be due to an inefficient organization of the new group and its partners.

    What should be pretty clear if things don't go well in China will probably not be a successful future for Trollhättan. This clearly shows, admittedly a few numbers smaller, the example of Borgward and his planned assembly plant in Germany.

Comments are closed.